-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

508. Bone Marrow Failure: Poster II

Bone Marrow Failure Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Santhosh Dhanraj, MSc1,2*, Sethu Madhava Rao Gunja, MSc3*, Adam P Deveau, BScH, MSc4*, Mikael Nissbeck, MSc3*, Boonchai Boonyawat, MD2*, Andrew J Coombs, BScH4*, Alessandra Renieri, MD5*, Mafalda Mucciolo, MD5*, Annabella Marozza, MD5*, Sabrina Buoni6*, Lesley Turner, MD7*, Hongbing Li, PhD2*, Ameer Jarrar, MSc4*, Mathura Sabanayagam, BSc2*, Melanie Kirby, MD8*, Mary Shago, PhD9, Dalila Pinto, PhD10*, Jason N. Berman, MD11, Stephen W. Scherer, PhD, FRSC2*, Anders Virtanen, PhD3* and Yigal Dror, MD, FRCP(C)1,2,12

1Institute of Medical Science, University of Toronto, Toronto, ON, Canada
2Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada
3Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden
4Department of Pediatrics, IWK Health Centre, Halifax, NS, Canada
5Medical Genetics, University of Siena, Siena, Italy
6Pediatric Neurology, University of Siena, Siena, Italy
7Discipline of Genetics, Memorial University of Newfoundland, St. John's, NF, Canada
8Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
9Cytogenetics Laboratory, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada
10Departments of Psychiatry, and Genetics and Genomic Sciences, Seaver Autism Center, The Mindich Child Health & Development Institute, Mount Sinai School of Medicine, New York, NY
11Pediatrics/Microbiology and Immunology, IWK Health Centre/Dalhousie University, Halifax, NS, Canada
12Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada

Wei Shi, Ph.D.1*, Therese Vu, BSc1*, Glen Boyle, Ph.D.1*, Fares Al-Ejeh, Ph.D.1*, Tej Pandita, Ph.D.2*, Krzysztof Ginalski, Ph.D.3*, Maga Rowicka, Ph.D.4*, Steven W. Lane, MD1,5,6 and Kum Kum Khanna, Ph.D.1*

1QIMR Berghofer Medical Research Institute, Brisbane, Australia
2The Houston Methodist Research Institute, Houston, TX
3University of Warsaw, Warsaw, Poland
4University of Texas Medical Branch, Galveston, TX
5Royal Brisbane and Women’s Hospital, Brisbane, Australia
6University of Queensland, Brisbane, Australia

Katie A Matatall, PhD1*, Mira Jeong, Ph.D.2, Sun Deqiang, PhD2*, Claudine Salire1* and Katherine Y. King, MD, PhD1,2

1Pediatric Infectious Diseases, Baylor College of Medicine, Houston, TX
2Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX

Patali S. Cheruku, B.Sc.1*, Ayla Cash, B.Sc.1*, Cynthia E. Dunbar, M.D.1, Neal S. Young, MD2 and Andre Larochelle, MD, PhD2

1National Heart, Lung and Blood Institute, Hematology Branch, National Institutes of Health, Bethesda, MD
2Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Anne-Laure Grignon, MD, BA, MA1, Daria V. Babushok, MD, PhD2,3, Li Yimei, phD4*, Helge Hartung, MD5, Ho-Sun Lam6*, Monica Bessler, MD, PhD7 and Timothy S. Olson, MD PhD8,9,10

1Children's Hospital of Philadelphia, Philadelphia, PA
2Division of Hematology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3Abramson Cancer Center, Department of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
4Perelman School of Medicine at the University of Pennsylvania, Department of Biostatistics and Epidemiology, Philadelphia, PA
5Department of Hematology/Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
6Bone Marrow Failure Center, Children's Hospital of Philadelphia, Philadelphia
7Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA
8Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
9Comprehensive Bone Marrow Failure Center, The Children's Hospital of Philadelphia, Philadelphia, PA
10Comprehensive Bone Marrow Failure Center, Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA

Lucia Gargiulo, PhD1*, Yoshitaka Zaimoku, MD2*, Barbara Scappini, MD3*, Hiroyuki Maruyama, MD2*, Rie Ohumi2*, Lucio Luzzatto, MD4, Shinji Nakao, MD, PhD2 and Rosario Notaro, MD1*

1Core Research Laboratory, Istituto Toscano Tumori, Florence, Italy
2Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
3Hematology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
4Istituto Toscano Tumori, Florence, Italy

Carlo Dufour, MD1, Silvia Ravera, PhD2*, Simone Cesaro, MD3*, Roberta Bottega, PhD4*, Cesare Usai, PhD5*, Cipolli Marco, MD6*, Anna Savoia7*, Paolo Degan, PhD8*, Michela Faleschini9*, Paola Cuccarolo10*, Marta Columbaro11*, Fabio Corsolini12* and Enrico Cappelli, PhD13*

1Istituto Giannina Gaslini, Genoa, Italy
2Università di Genova, Genova, Italy
3Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy
4I.R.C.C.S. "Burlo Garofolo", Trieste, Italy
5CNR, genova, Italy
6Azienda Ospedaliera Universitaria Integrata, Verona, Italy
7IRCCS Burlo Garofolo, Trieste, Italy
8IRCCS AOU San Martino - IST, Genova, Italy
9I.R.C.C.S., Trieste, Italy
10IRCCS AOU San Martino - IST, genova, Italy
11Istituto Ortopedico Rizzoli, Bologna, Italy
12Ospedale G. Gaslini, genova, Italy
13Ospedale G. Gaslini, Genova, Italy

Youngme Yoon, B.S.1*, Ashley N. Kamimae-Lanning, Ph.D.2*, Kelsie Storm, MD2, Natalya A Goloviznina, B.S.3* and Peter Kurre, MD4

1Pediatrics, Oregon Health & Science University, Portland, OR
2Papé Family Pediatric Research Institute, Oregon Stem Cell Center, Oregon Health & Science University, Portland, OR
3University of Minnesota, Minneapolis, MN
4Pediatrics Papé Family Pediatric Research Institute; Knight Cancer Institute; Cell & Developmental Biology, Oregon Health & Science University, Portland, OR

Erik Westin, PhD1*, Larisa Pereboeva, MD, PhD2, Divya Devadasan, MS1*, Tim M. Townes, PhD3 and Frederick D Goldman, MD4

1University of Alabama at Birmingham, Birmingham, AL
2Univ. of Alabama At Birmingham, Birmingham, AL
3Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute, University of Alabama at Birmingham, Birmingham, AL
4Department of Pediatrics, Division of Hematology Oncology, Children's Hospital of Alabama, University of Alabama at Birmingham, Birmingham, AL

Anita Hill1*, Jorg Taubel2*, Jim Bush3*, Anna Borodovsky4*, Noriyuki Kawahata4*, Helen Mclean4*, Christine Powell4*, Prasoon Chaturvedi5*, Garvin Warner4*, Pushkal Garg4* and Benny Sorensen4

1St James' Institute of Oncology; Leeds Teaching Hospitals, Leeds, United Kingdom
2St George's University of London, London, United Kingdom
3Covance Clinical Research Unit, Leeds, United Kingdom
4Alnylam Pharmaceuticals, Cambridge, MA
5Alnylam Pharmaceutical, Cambridge, MA

Ayodele Alaiya, MPH, MBBS, PhD, FRCPath1*, Hazza A Alzahrani, MD2*, Zakia Shinwari, MSc3*, Tarek Owaidah, MD, FRCPA4, Fahad Al Mohareb, MD5*, Fahad Al Sharif, MD6*, Randa Al Nounou, MD7*, Naeem A. Chaudhri, MD, FACP2, Ghuzayel Aldawsari, MD2*, Amr Hanbali, MD8*, Marwan Shaheen, MD2*, Feras Alfraih, MD2*, Syed Osman Ahmed, MD, MRCP, FRCPath8* and Mahmoud Aljurf, MD, MPH2

1Proteomics Unit, Stem Cell & Tissue Re-Engineering Program, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
2King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
3Proteomics Unit, Stem cell and Tissue Re-Engineering Program, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
4Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
5Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
6King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
7Department of Pathology and Laboratory Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
8Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Luis Espinoza, MD, PhD1*, Yoshinori Yoshida, MD, PhD2*, Kazuhisa Chonabayashi, MD, PhD3*, Takamasa Katagiri, PhD4*, Yoshitaka Zaimoku, MD5* and Shinji Nakao, MD, PhD5

1Kanazawa University, Kanazawa, Japan
2Center for iPS cells Research and Application, Kyoto University, Kyoto, Japan
3Department of Reprogramming Science, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan
4Graduate School of Medical Science, Clinical Laboratory Sciences, Kanazawa University, Kanazawa, Japan
5Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan

Nicolas Waespe, MD1,2, Santhosh Dhanraj, BSc, MSc1,3*, Manju Wahala, MD1*, Tom Enbar1*, Bozana Zlateska1*, Hongbing Li, PhD1*, Robert J. Klaassen, MD, FRCP4, Conrad Fernandez, MD5, Rochelle Yanofsky, MD, FRCP(C)6*, John K. Wu, MBBS, MSc, FRCPC7, Yves D. Pastore, MD8, Mariana Silva, MD, FRCPC9*, Jeffrey H. Lipton, MD, PhD10, Josee Brossard, MD11*, Bruno Michon, MD, FRCPC12*, Sharon Abish, MD13, MacGregor Steele, MD, FRCP(C)14, Roona Sinha, MD15*, Mark J. Belletrutti, MD, MSc16, Vicky R. Breakey, BSc, MD, MEd, FRCPC17, Lawrence Jardine, MD, BA, FRCPC18, Lisa Goodyear, MD, FRCPC19*, Liat Kofler1*, Ibrahim A. Ghemlas, MD1,20*, Michaela Cada, MD, FRCPC, FAAP, MPH2, Lillian Sung, MD, PhD21, Mary Shago, PhD22, Stephen W. Scherer, PhD, FRSC1* and Yigal Dror, MD, FRCP(C)1,2,23

1Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada
2Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
3Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada
4Department of Pediatrics, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada
5Pediatric Hematology/Oncology, IWK Health Centre, Halifax, NS, Canada
6Pediatric Hematology/Oncology, University of Manitoba, CancerCare Manitoba, Winnipeg, MB, Canada
7Division of Hematology/Oncology, UBC & B.C. Children's Hospital, Vancouver, BC, Canada
8CHU Sainte-Justine, Montreal, QC, Canada
9Kingston General Hospital, Kingston, ON, Canada
10Allogeneic Blood and Marrow Transplant Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
11Centre hospitalier universitaire, Sherbrooke, QC, Canada
12Centre Hospitalier Universitaire de Quebec, Sainte-Foy, QC, Canada
13Pediatric Hematology Oncology, Montreal Children's Hospital, Montreal, QC, Canada
14Alberta Children's Hospital, Calgary, Canada
15Royal University Hospital, Saskatoon, SK, Canada
16Pediatrics, University of Alberta, Edmonton, AB, Canada
17Department of Pediatrics, McMaster University, Hamilton, ON, Canada
18Children's Hospital, London Health Sciences Centre, London, ON, Canada
19Pediatric Hematology/Oncology, Janeway Child Health Centre, St. John's, NF, Canada
20Department of Pediatric Hematology/Oncology, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia
21Population Health Sciences, Research Institute, Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada
22Cytogenetics Laboratory, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada
23Institute of Medical Science, University of Toronto, Toronto, ON, Canada

Racheli Ofir, PhD1*, Lena Pinzur2*, Akyüz Levent3*, Zami Aberman2*, Raphael Gorodetsky, PhD4* and Hans Dieter Volk, PhD3*

1Pluristem Therapeutics Inc. - Haifa, Israel, HAIFA, Israel
2Pluristem Therapeutics, Haifa, Israel
3Charité - Universitätsmedizin Berlin, Berlin, Germany
4Hadassah - Hebrew University Medical Center, Jerusalem, Israel, HAIFA, Israel

Noriharu Nakagawa, MD*, Hiroyuki Maruyama, MD*, Yoshitaka Zaimoku, MD*, Kana Maruyama, MD*, Chizuru Saito, MD*, Takamasa Katagiri, PhD*, Kohei Hosokawa, MD, PhD*, Ken Ishiyama, MD, Ph.D., Hirohito Yamazaki, MD, PhD* and Shinji Nakao, MD, PhD

Cellular Transplantation Biology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan

*signifies non-member of ASH